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Abstract
Background: Phosphatidylserine is the phospholipid component which plays a key role in cell cycle signaling,
specifically in regards to necrosis and apoptosis. When a cell affected by some negative factors, phosphatidylserine
is no longer restricted to the intracellular side of membrane and can be translocated to the extracellular surface of
the cell. Cryopreservation can induce translocation of phosphatidylserine in response to hypoxia, increasing
intracellular Ca2+, osmotic disruption of cellular membranes, generation of reactive oxygen species and lipid
peroxidation. As such the aim of this study was to test the level of phosphatidylserine translocation in frozen
human medulla-contained and medulla-free ovarian tissue fragments.
Methods: Ovarian fragments from twelve patients were divided into small pieces of two types, medulla-free cortex
(Group 1, n = 42, 1.5–3.0 × 1.5–3.0 × 0.5–0.8 mm) and cortex with medulla (Group 2, n = 42, 1.5–3.0 × 1.5–3.0 × 1.5–2.
0 mm), pre-cooled after operative removal to 5 °C for 24 h and then conventionally frozen with 6 % dimethyl
sulfoxide, 6 % ethylene glycol and 0.15 M sucrose in standard 5-ml cryo-vials. After thawing at +100 °C and step-
wise removal of cryoprotectants in 0.5 M sucrose, ovarian pieces were xenografted to SCID mice for 45 days. The
efficacy of tissues cryopreservation, taking into account the presence or absence of medulla, was evaluated by the
development of follicles (histology with hematoxylin-eosin) and through the intensity of translocation of
phosphatidylserine (FACS with FITC-Annexin V and Propidium Iodide).
Results: For Groups 1 and 2, the mean densities of follicles per 1 mm3 were 9.8, and 9.0, respectively. In these
groups, 90 and 90 % preantral follicles appeared morphologically normal. However, FACS analysis showed a
significantly decreased intensity of translocation of phosphatidylserine (FITC-Annexin V positive) after
cryopreservation of tissue with medulla (Group 2, 59.6 %), in contrast with tissue frozen without medulla (Group 1,
78.0 %, P < 0.05). In Groups 1 and 2 it was detected that 21.6 and 40.0 % cells were viable (FITC-Annexin V negative,
Propidium Iodide negative).
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Conclusion: The presence of medulla in ovarian pieces is beneficial for post-thaw development of cryopreserved
human ovarian tissue.
Keywords: Cancer, Cryopreservation, Human ovarian tissue, Phosphatidylserine translocation, Medulla,
Xenotransplantation
Background
One of the major death causes in the world is cancer.
Incidences of cancer are increasing worldwide. In the
USA alone, 1,685,210 new cancer cases and 595,690
cancer deaths are projected to occur in 2016 [1]. Fur-
thermore the overall incidence rate for cancer in chil-
dren aged 14 years and younger increased by 0.6 % per
year between 1998 and 2007 [2].
A similar trend has been observed in Europe. Every
year in Germany, around 800 girls under age 15 are di-
agnosed with cancer [3]. At the same time, increased
survival rates were observed for all categories of child-
hood cancers studied, with the extent and temporal pace
of the increases varying by diagnosis [4].
Fortunately, recent progress in cancer therapies has
significantly decreased mortality rates. However, these
therapies whilst often curative often cause significant
side effects, including reduced fertility and sterility. For
young women surviving cancer this is often a major
concern [4]. As such, cryopreservation of ovarian tissue
before cancer therapy with re-implantation after conva-
lescence could offer a viable and more successful alter-
native to current fertility preservation option [5, 6].
Since 1998 several cases reporting restoration of ovar-
ian function after re-implantation of ovarian cortex in
patients with premature ovarian failure after cryopreser-
vation of ovarian tissue before the cancer treatment have
been published. Furthermore, over 60 live births follow-
ing cryopreservation and retransplantation of frozen
ovarian tissue have been reported [7].
The intracellular side of the cell membrane is made up
of phosphatidylserine, the phospholipid component that
plays a key role in cell cycle signaling, necrosis and
apoptosis. When conditions change and hypoxia is in-
duced, phosphatidylserine is can be translocated to the
extracellular surface of the cell and is not just restiructed
to intracellular membrane. When this occurs it signals
the macrophages to engulf the cells [8].
There are at least five factors that are observed during
cryopreservation which induce translocation of phospha-
tidylserine: hypoxia, increasing of intracellular Ca2+,
osmotic disruption of cellular membranes, generation of
reactive oxygen species (ROS) and lipid peroxidation.
As usual research groups remove the medulla from
the cortex when preparing the ovarian tissue for cryo-
preservation as the cortex contains the majority of the
follicles. However, there is still a significant number of fol-
licles within the medulla [9] and most importantly, blood
vessels. As such we postulate that keeping the medulla
may support neovascularisation in re-implanted tissues.
Consequently, the aim of this study was to compare
the viability of follicles in cryopreserved medulla-
containing and medulla-free human ovarian cortex by
evaluating the intensity of the phosphatidylserine trans-
location after thawing and xenografting.
Methods
This study was approved by the Ethics Boards of
Universitiy Cologne (applications 99184 and 13–147).
Manipulations with SCID mice were approved by the
Animal Care Commission at the Institute of Micro-
biology, Sofia, Bulgaria.
Written informed consents were obtained from all
participants aged 18 and over involved in our study. On
the behalf of the patients under the age of 18 written
consents were obtained from the next of kin.
Except where otherwise stated, all chemicals were
obtained from Sigma (Sigma Chemical Co., St. Louis,
MO, USA).
Tissue collection, dissection, and distribution into groups
Informed consent was obtained from 12 patients aged
between 13 and 36 (25.1 ± 4.0) years. According to our
approved protocol 10 % of ovarian tissue collected from
patients was used for ‘patient- oriented’ research. This
refers to research which is done in order to assess the
viability of the tissue for re-transplantation.
The medium used for transport and dissection, the
basal medium, was comprised of Leibovitz L-15 with
5 % Dextran Serum Substitute (Irvine Scientific, Santa
Ana, CA, USA).
Following collection the fresh ovarian tissue fragments
were transported to the laboratory within 20 min of
surgery. The temperature of the sample was maintained
between 32 and 34 °C. Using tweezers and scalpel No
22, ovarian fragments were dissected into small pieces
(Group1, medulla-free fragments: 1.5–3.0 × 1.5–3.0 ×
0.5–0.8 mm and Group 2, medulla-contained frag-
ments: 1.5–3.0 × 1.5–3.0 × 1.5–2.0 mm). Then pieces
were cooled at 5 °C for 24 h and on the next day frozen
as described below.
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In total forty-four pieces, corresponding to two pieces
per mouse, in each experimental group, were used to
determine the quality of follicles and the degree of phos-
phatidylserine translocation.
Tissue cryopreservation (freezing and thawing)
This procedure was performed as published previously [10].
Ovarian tissue was frozen in Germany, then transported,
thawed and transplanted to SCID mouse in Bulgaria.
On the day of freezing, pieces of ovarian tissue were
placed for 30 min at room temperature in 20 ml freezing
medium composed of basal medium supplemented with
6 % dimethyl sulfoxide, 6 % ethylene glycol and 0.15 M
sucrose. Then pieces were put into a standard 5-ml
cryo-vials (Thermo Fisher Scientific, Rochester, NY,
USA) previously filled by 4.5 ml freezing medium and
frozen in a IceCube 14S freezer (SyLab, Neupurkersdorf,
Austria). The slow cooling profile started at -6 °C, the
samples were then cooled from −6 to −34 °C at a rate
of −0.3 °C/min. At −34 °C cryo-vials were finally
plunged into liquid nitrogen and stored until thawing.
The freezing protocol for cryopreservation of this ovarian
tissue included auto-seeding step at −6 °C.
In order to thaw the samples, cryo-vials were removed
from liquid nitrogen and held for 30 s at room
temperature, they were then immersed in a 100 °C (boil-
ing) water bath for 60 s. The exposure time in the boil-
ing water was visually controlled by the presence of ice
in the medium; as soon as the ice was 2 to 1 mm apex,
the cryo-vial was removed from the boiling water, at
which point the final temperature of the medium was
between 4 and 10 °C. Within 5–10 s after thawing, the
pieces from the cryo-vials were transferred to a 10 ml
thawing solution (basal medium containing 0.5 M
sucrose) in a 100 ml specimen container (Sarstedt,
Nuembrecht, Germany). For stepwise dilution of cryo-
protectants, the container was placed on a shaker and
continuously agitated with 200 osc/min for 15 min at
room temperature.
This was performed using the same, previously pub-
lished [10] ‘dropping’ methodology: slow addition of
basal medium to the solution of sucrose with ovarian
pieces. For ‘dropping’, we used 50 ml of basal medium in
a 50 ml tube (Greiner Bio-One GmbH, Frickenhausen,
Germany). The final sucrose concentration was 0.083 M,
resulting in almost isotonic conditions [10]. The last step
involved three washes in basal medium for 10 min
immediately prior to transplantation into SCID-mice.
Xenografting of ovarian tissue
Twenty-two, female, 7 week SCID (BALB/c) mice were
obtained from Harlan Farm (Blackthorn, UK). The
animals were kept in specific- pathogen-free (SPF)
conditions with equal 12-h light and dark conditions
and provided with food and water ad libitum.
Immediately following thawing, ovarian pieces were
transplanted to SCID mice as previously described
[11–13] (Fig. 1). During surgery, the mice were kept
on a warming plate and the procedure was carried out
under sterile conditions. A combination of anesthetic
Rompun 2 % (Bayer Vetal Leverkusen, Germany) and
Ketanest 50 mg/ml (Parke-Davis Freiburg, Germany) was
used for sedation. In each mouse the tissue pieces were
grafted dorsolateral on the right and left side of the verte-
bral column. Tissue from the same patient was used in
parallel to the group with medulla and the group without
medulla. Every second day the mice were injected with
1.0 IU of recombinant FSH (Gonal-F®, Laboratories Ser-
ono S.A., Aubonne, Switzerland). The animals were killed
by cervical dislocation on the 45th day after transplant-
ation. The recovered grafts were dissected into two parts:
the first processed for measurement of phosphatidylserine
translocation and the second fixed for histological
investigation.
Phosphatidylserine translocation: flow cytometry
The human tissue was recovered from the mice and
replaced to PBS with 10 % fetal calf serum (FCS). Then
the tissue was incubated in GM 501 Collagenase
(Gynemed GmbH, Lensahn, Germany) for 1 h at 370C
while being continually shaking. At the end of the hour
the reaction was stopped by addition of ice cold PBS-
FCS, followed by mechanical disruption of the tissue
through 20G syringe needle and passing through 70 μm
filter on ice. The cells were centrifuged at 1000 RPM at
40C for 10 min in PBS-FCS and then suspended in 1 ml
PBS-FCS.
The isolated cells were cultured in complete RPMI
1640 (Roswell Park Memorial Institute medium, Gibco,
Gaithersburg, MD, USA) containing 10 % FCS, 4 mM L-
glutamine, 50 μM 2-mercaptoethanol and antibiotics for
1 h at 37 °C in 5 % CO2. Then cells were collected,
washed and stained with a FITC-Annexin V apoptosis
detection Kit I (BD Biosciences, San Diego, CA, USA),
containing Propidium Iodide (PI) as DNA-binding dye
in accordance with instruction of manufacturer. The
apoptosis of gated cells was analyzed within 15 min.
using flow cytometry (BD LSR II flow cytometer). The
rate of phosphatidylserine translocation as detector of
early apoptosis (FITC-Annexin V positive, PI negative)
and late apoptosis and dead cells (FITC-Annexin V posi-
tive, PI positive), as well as necrosis (FITC-Annexin V
negative, PI positive) was measured.
Histology of follicles
For histological investigation, the grafted tissue pieces
were fixed in Bouin’s solution, embedded in paraffin wax,
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serially sectioned at 4 μm, stained with hematoxylin/eosin,
and analyzed under a microscope (×400, Olympus Co,
Tokyo, Japan).
The number of viable and damaged follicles was
counted. Before counting of follicles, sections were coded
and scored “blind”. To avoid over-counting the same folli-
cles, only sections with a visible oocyte nucleus were ana-
lysed. Two types of preantral follicles were evaluated: 1)
primordial follicles composed of an oocyte surrounded by
a layer of flattened follicular cells and 2) primary and
secondary follicles which are similar to primordial follicles,
but in which the oocyte is surrounded by one to two layers
of spheroid granulosa cells.
Morphology of the follicles was evaluated on the basis
of parameters previously described [14]. Here we have
slightly modified the mentioned [14] description. The
quality of follicles was graded on a scale from one to three.
A follicle of grade 1 is spherical in shape and contains a
spherical oocyte which is surrounded by an even distribu-
tion of granulosa cells and has a homogenous cytoplasm
and slightly granulated nucleus, with condensed chro-
matin in the form of a dense spherical structure de-
tectable in the center of the nucleus. A follicle of
grade 2 has similar characteristics, but the oocyte is
without condensed chromatin within the nucleus and
is often irregular in shape; the surrounding granulosa
cells can be flat and pulled away from the edge of
the follicle. A follicle of grade 3 contains a misshapen
oocyte with or without nuclear vacuolation; theca and
granulosa cells are separated from the edge of the fol-
licle and the partly or fully disrupted granulosa have
pyknotic nuclei [14]. Follicles of grades 1 and 2 were
classified as normal and those of grade 3 as degener-
ated. Follicles were classified as degenerate if they
had one or more of the following aspects: condensed
oocyte nucleus; shrunken oocyte; nonhomogeneous
ooplasm; pycnotic bodies in the granulosa cells; or
low cellular density [15]. Examples of different follicu-
lar degenerations can be observed elsewhere [16, 17].
Statistical analysis
Different rates of tissue after treatment was evaluated
using ANOVA. Orthogonal contrasts were used to
separate main effects. The level of statistical significance
was set at a P <0.05.
Results
After 45 days of development histological examination
was conducted and only preantral (primordial, primary
Fig. 1 Xenografting of cryopreserved human ovarian tissue. a
Cryopreserved ovarian pieces just after thawing, b, c
Transplantation of these pieces, d Ovarian piece after 45 d in
vivo culture. Scale bar: 2 mm
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and secondary) follicles were viable. All the antral folli-
cles in these two groups were degenerated and hence
were not included in the counts.
For Group 1 and Group 2, the mean densities of
follicles per 1 mm3 were 9.8 ± 2.3, and 9.0 ± 3.1, re-
spectively (P > 0.1). For these groups, 89.7 ± 5.2 and
90.1 ± 6.7 % preantral follicles were morphologically
normal (P > 0.1) (Fig. 2).
In Group 1 (ovarian tissue, which was frozen in form
of medulla-free cortex) 12.4 ± 2.2 % of cells were in early
apoptotic state (FITC-Annexin V positive, PI negative),
while 65.6 ± 5.6 % of cells showed characteristics of late
apoptotic state or dead cells (FITC-Annexin V positive,
PI positive). In this group 21.6 ± 2.2 % were viable cells
(FITC-Annexin V negative, PI positive) and 0.4 ± 0.05 %
were necrotic cells (FITC-Annexin V negative, PI posi-
tive) (Figs. 3 and 4).
In Group 2 (ovarian tissue containing medulla) 12.5 ±
3.0 % of the cells were observed to be an early apop-
totic state and 47.1 ± 3.1 % of the cells in a late apop-
totic state. In this group 40.0 ± 4.2 % of the cells were
viable and 0.4 ± 0.05 % of the cells were necrotic
(Figs. 3 and 4).
Discussion
In order to prevent crystallization of intracellular water
at a cooling of mammalian ovarian tissues, permeable
cryoprotectants are used to protect the cells. The main
cryoprotectants are three glycols (high molecular alco-
hols: glycerol, propylene glycol and ethylene glycol) as
well as dimethyl sulfoxide (DMSO) [18]. The ‘protective’
component is usually 10 to 12 % of the total salutation
and is either made up from a single solution, often
DMSO or a mixture of two cryoprotectants DMSO and
one of the glycols [18]. In our protocol we used DMSO
and ethylene glycol as we believe that ovarian tissue is
multi-cellular organ and therefore requires for multi-
cryprotectants in order to protect all types of cells. Fur-
thermore, in a previous unpublished study we discovered
that the effectiveness of 12 % DMSO alone was lower
than a multi solution cryoprotectant in the same total
concentration (12 %) (V. Isachenko, not published data).
The routine protocol of cryopreservation of ovarian tis-
sue in our clinic presupposes the obvious long-time pre-
cooling of tissue before freezing. It is because we have
previously established that the 24 h cooling to 5 °C before
cryopreservation is beneficial for cryopreservation of hu-
man ovarian tissue [19].
During cryopreservation, at least 5 negative side effects
have been observed: hypoxia, increasing of intracellu-
lar Ca2+, osmotic disruption of cellular membranes,
generation of reactive oxygen species (ROS) and lipid
peroxidation. Each can lead to translocation of
phosphatidylserine.
Fig. 2 Effect of the containing of medula on the quality of follicles (expressed as quantity and normality of follicles). No statistical
differences between respective rates (P > 0.1)
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Fig. 3 (See legend on next page.)
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Phosphatidylserine is the phospholipid component of
membrane which plays a key role in cell cycle signaling,
specifically in relationship to necrosis and apoptosis.
Phosphatidylserine is normally located on the inner
side of the cell membrane. However, when a cell
affected by some negative factors, phosphatidylserine
is no longer restricted to the intracellular side of
membrane and translocated to the extracellular sur-
face of the cell, they act as a signal for macrophages
to engulf the cells [8].
It has been noted that during cryopreservation, a cell
initiates intracellular apoptotic or necrotic signaling in
response to a stress. The binding of nuclear receptors by
heat, hypoxia [20] and increased intracellular calcium
concentration [21], can all trigger the release of intracel-
lular apoptotic signals by a damaged cell. Apoptotic pro-
teins that target mitochondria affect them in different
ways. They can cause mitochondrial swelling through
the formation of membrane pores, or they may increase
the permeability of the mitochondrial membrane and
cause apoptotic effectors to leak out [20].
Apoptosis is a major cause of sperm damage during
cryopreservation [22]. It was established that in human
ovarian tissue the percentage of apoptotic follicles
was significantly higher in cryopreserved compared to
fresh tissue at baseline (15 % vs. 4 %), indicating that
cryopreservation process itself induces apoptosis in
follicles [23].
In the early 1990s other research groups concluded
that the translocation of phosphatidylserine played the
role of detector of apoptosis [24]. However, it was later
established that phosphatidylserine translocation may
actually be reversible and also occurs in T-cell activation,
without cell death [25].
Furthermore, it was found that phosphatidylserine
translocation on the outer surface plasma membrane is
less universal and more context dependent than previ-
ously thought [26]. Galluzzi et al. [26] published that
using phosphatidylserine alone as a marker of early
apoptosis, it should be noted that (1) if plasma mem-
branes are permeabilized (as during late apoptosis or
early necrosis) Annexin V can bind to intracellular
phosphatidylserine; (2) phosphatidylserine translocation
can prepare cells for phagocytic removal independently
of apoptosis [27] and that (3) phosphatidylserine trans-
location can be compromised in cells in which autoph-
agy is impaired [28].
As noted, a ‘specific’ cell death-related phenomenon
may occur along with the execution of another cell death
mode. For instance, excessive generation of reactive
(See figure on previous page.)
Fig. 3 Translocation of phosphatidylserine in ovarian tissue frozen in form of medulla-free and medulla-contained strips and then xenografted in
SCID mice: representative example of one experiment. a, b, c, d, e tissue frozen in form of medulla-free cortex, f, g, h, i, j tissue frozen in form of
medulla-contained cortex, a, f forward and scatter dot plot used to select the interest population, c, h histograms displaying fluorescence of PE
channel, used to measure fluorescence intensity of Propidium Iodide (PI), (D, I) dot plot analysis of FITC-Annexin V and PE channels, (Q1) cells
negative to Annexin V (FITC A) and positive to PI (could indicate necrotic cells), (Q2) cells positive to both Annexin V and PI (could indicate late
apoptotic stage), (Q3) cells negative for both Annexin V and PI (could indicate viable cells), (Q4) cells positive to FITC-Annexin V and negative to
PI (could indicate early apoptotic state)
Fig. 4 Translocation of phosphatidylserine in ovarian tissue frozen in form of medulla-free and medulla-contained strips and then xenografted in
SCID mice. * Cells in early apoptotic state (FITC-Annexin V positive, PI negative). ** Cells in late apoptotic state or dead cells (FITC-Annexin V
positive, PI positive). *** Viable cells (FITC-Annexin V negative, PI positive). **** Necrotic cells (FITC-Annexin V negative, PI positive). Different
superscripts indicate statistical differences between respective rates (P < 0.05)
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oxygen species (ROS) and reactive nitrogen species has
been associated with several cases of apoptosis [29, 30].
Increased membrane permeability is a signal for early
apoptosis in somatic cells [31].
When discussing our results we try to avoid the word
‘apoptosis’. As such, we evaluated the translocation of
phosphatidylserine after respective cryo-treatment not as
detector of apoptotic changes in cells but as a detector
of viability of these cells after cryopreservation. By doing
so we were able to determine the successes of various
cryopreservation protocols. When the tissue was cryo-
preserved with the medulla there was a lower level of
translocation compared to when the tissue was proc-
essed as cortex alone thereby allowing us to conclude
that the medulla improves the freezing process.
In the number of publications the first stage in ovarian
tissue cryopreservation has usually been the isolation of
cortex from medulla [6]. This procedure allows the cryo-
preservation of primordial follicles, which are small and
cryo-resistant structures [32, 33]. Usually slices of
medulla-free cortex are prepared for cryopreservation.
However, the ovarian medulla has two crucial character-
istics: the presence of follicles and blood vessels. Follicle
density in the medulla can reach 9824 follicles/g of me-
dulla, and a considerable number of pre-antral follicles
are lost when the medulla is discarded as required in
current practice cortical tissue isolation prior to cryo-
preservation [9].
Therefore we attempted to answer if medulla-mediated
promotion of neovascularization is advantageous for re-
implanted ovarian cortex? And what advantage neo-
vascularization may add to the preservation and/or devel-
opment of follicles after transplantation?
The presence of blood vessels is essential for success-
ful ovarian graft transplantation, required for the rapid
establishment of the blood supply which is crucial for
the survival of ovarian follicles [34]. It has been shown
that transplanted immature rat ovaries become profusely
re-vascularised within 48 h after autotransplantation
[35]. In the cortex, development of primordial follicles is
fully dependent on stromal vessels [36]. Prior to revascu-
larisation, implants are vulnerable to ischemia, which is
the main obstacle for the survival of tissue after trans-
plantation. Such damage can lead to 30–70 % reduction
in graft size accompanied with fibrotic changes [37].
The hypoxia observed during the first 5 days after
grafting and ischemic damage occurring during this
period could induce primordial follicle loss [38–40]
and disorders of follicular activation [41, 42]. The
presence of medullary material in ovarian cortex
pieces could be expected to improve the chances of
revascularization of transplanted ovarian tissue. It ap-
pears that the presence of medullar material in the
ovarian pieces leads to better vascularization and is
crucially needed for angiogenesis [43]. It can be in-
ferred that inclusion of medulla would be of import-
ant advantage when such pieces are re-implanted into
their female sources.
Comparative investigations of the role of medulla in
human ovarian tissue are limited. Although, interesting
comparative investigations in this field were performed
by Revel et al., 2011 [44].
A 19-year-old woman had tissue from one of her ovar-
ies cryopreserved prior to bone marrow transplantation,
total body irradiation and sterilizing chemotherapy. As
expected, premature ovarian failure resulted after treat-
ment. Before cryopreservation of ovarian fragments, most
of the ovarian medulla was removed and the resulting
ovarian cortex tissue was manually cut into pieces varying
in size from 0.8 to 1.4 cm in length, 2–4 mm in depth and
1.5–2.0 mm in width prior to cryopreservation [44].
Following thawing, eight pieces of ovarian cortex were
transplanted. After ovarian transplantation, authors ob-
served a decrease in FSH levels as well as an increase in
estradiol. Authors noted that following three IVF cycles
obtaining three poor quality embryos, the transplanted
ovarian tissues stopped responding as ovulation induc-
tion failed to induce follicle development [44].
Later a second ovarian transplantation via laparoscopy
revealed an atrophic left ovary with no follicles. The
neo-ovarian tissue in the right broad ligament appeared
to be vascularized yet no follicular structure was visible
in the area where the tissue had been re-implanted.
Biopsies of both sides were sent to histology and showed
the presence of fibrotic tissue and no follicles. Authors
created a peritoneal pocket, inserted thawed ovarian
pieces into the right broad ligament and sutured the
pocket. Following the second ovarian transplantation,
authors again observed a decrease in FSH levels as well
as an increase in estradiol [44]. However, it was noted
that ovulation induction was not helpful. Four IVF cycles
produced a total of six oocytes and two poor quality em-
bryo transfers that failed to implant. Following repeat
ovarian failure and no follicular response despite admin-
istration of maximal FSH doses, authors decided to
modify the protocols before offering a third ovarian
transplantation [44].
For the third ovarian transplantation, the 0.35 mm
pieces were used. On the fourth IVF cycle, two mature
oocytes were retrieved from the right transplanted tissue,
yielding two good quality embryos, which were trans-
ferred and resulted in a pregnancy and live birth, which
was achieved when thinner ovarian fragments without
medulla were prepared prior to transplantation. As a re-
sult of the success, the authors concluded that making
the fragments only a few hundred microns thick allows
appropriate diffusion of gases and nutrients thereby pre-
serving follicle viability.
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Other research group describes separating the medulla
from the cortex prior to tissue freezing [45]. However,
they also recommend to do transplantation of up to
2 mm fragments which are comprised of both medulla
and cortex and such the tissue is not in fact separated
[45].
The following studies do indirectly support our con-
clusion that the presence of medulla in ovarian pieces is
beneficial for post-thaw development of cryopreserved
human ovarian tissue. The aim of this study was to de-
termine the best source of isolated ovarian cells for the
artificial ovary: cortex or medulla [46].
Ovarian tissue was retrieved from patients, and the
ovarian cells from the cortex and medulla were isolated
separately. Their viability was tested using a calcein
AM/ethidium homodimer viability assay. Cells were
then encapsulated in fibrin and grafted to peritoneal
pockets in nude mice. Grafts recovered after 7 days were
analyzed by immunohistochemistry for the presence of
ovarian cells (Vimentin), proliferation (Ki67) and graft
vascularization (double CD34). Cell apoptosis was ana-
lyzed by TUNEL assay [46].
Authors have concluded that ovarian cells from me-
dullary tissue, which can be isolated in larger numbers,
show higher viability and are able to improve graft
vascularization [46].
Conclusions
The presence of medulla in ovarian pieces is beneficial
for post-thaw development of cryopreserved human
ovarian tissue. For medical practice it is recommended
to prepare ovarian medulla-contained strips.
Abbreviations
FACS: Fluorescence-activated cell sorting; FITC: Fluorescein isothiocyanate (a
chemical compound); FSH: Follicle stimulating hormone; IU: International
unites; PM: Revolutions per minute; ROS: Reactive oxygen species;
SCID: Severe combined immunodeficiency
Acknowledgements
The authors are very grateful to Dr. Pamela Uribe from University Temuco,
Chile for helpful discussion of our results.
Funding
The authors did not receive any specific funding for this study.
Availability of data and materials
The datasets supporting the conclusions of this article are included within
the article.
Authors’ contributions
Conceived and designed the experiments: VI, PT, EI, GR, AT, PH, NG, PM, MM,
performed the experiments: VI, EI, PT, AT, NG, PH, analyzed the data: GR, PM,
MM, contributed reagents/materials/analysis tools: BH, MS, GR, wrote the
manuscript: VI, EI, GR, PM, MM, manuscript drafting and critical discussion: VI,
PT, EI, GR, AT, PH, PM, MM, finally approved of the version to be published:
PH, NG. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
This study was approved by the Ethics Boards of Universitiy Cologne
(applications 99184 and 13–147). Manipulations with SCID mice were
approved by the Animal Care Commission at the Institute of Microbiology,
Sofia, Bulgaria. Written informed consents were obtained from all
participants aged 18 and over involved in our study. On the behalf of the
patients under the age of 18 written consents were obtained from the next
of kin.
Author details
1Research Group for Reproductive Medicine and IVF-Laboratory, Department
of Obstetrics and Genecology, Cologne University, Kerpener Str. 34, 50931
Cologne, Germany. 2Institute of Biology and Immunology of Reproduction,
Tzarigradsko shosse 73, 1113 Sofia, Bulgaria. 3Laboratory of Experimental
Immunology, Institute of Microbiology, Acad. G. Bonchev Street, Block 26,
1113 Sofia, Bulgaria. 4Institute of Women’s Health, University College London,
London, UK. 5MedEvent Dr. Merzenich GmbH, Im Zollhafen 12, 50678
Cologne, Germany.
Received: 29 July 2016 Accepted: 3 November 2016
References
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin.
2016;66:7–30.
2. Kohler BA, Ward E, McCarthy BJ, Schymura MJ, Ries LA, Eheman C, et al. Annual
report to the nation on the status of cancer, 1975–2007, featuring tumors of
the brain and other nervous system. J Natl Cancer Inst. 2011;103:1–23.
3. Kaatsch P, Spix C, Hentschel S, Katalinic A, Luttmann S, Stegmaier CH, et al.
Cancer in Germany 2005/2006. “Abundances and trends”. A joint
publication of the Robert Koch Institute and the Association of Cancer
Registries in Germany. Berlin; 2010. p.144.
4. Smith M, Seibel N, Altekruse S, Ries LA, Melbert DL, O’Leary M, et al.
Outcomes for children and adolescents with cancer: challenges for the
twenty-first century. J Clin Oncol. 2010;28:2625–34.
5. Dittrich R, Maltaris T, Hoffmann I, Oppelt PG, Beckmann MW, Mueller A, et al.
Fertility preservation in cancer patients. Minerva Ginecol. 2010;62:63–80.
6. von Wolff M, Donnez J, Hovatta O, Keros V, Maltaris T, Montag M, et al.
Cryopreservation and autotransplantation of human ovarian tissue prior to
cytotoxic therapy-a technique in its infancy but already successful in fertility
preservation. Eur J Cancer. 2009;45:1547–53.
7. Donnez J, Dolmans MM. Ovarian tissue freezing: current status. Curr Opin
Obstet Gynecol. 2015;27:222–30.
8. Verhoven B, Schlegel R, Williamson P. Mechanisms of phosphatidylserine
exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J
Exp Med. 1995;182:1597–601.
9. Kristensen SG, Rasmussen A, Byskov AG, Andersen CY. Isolation of pre-antral
follicles from human ovarian medulla tissue. Hum Reprod. 2011;26:157–66.
10. Isachenko V, Isachenko E, Reinsberg J, Montag M, van der Ven K, Dorn C,
et al. Cryopreservation of human ovarian tissue: comparison of rapid and
conventional freezing. Cryobiology. 2007;55:261–8.
11. Rahimi G, Isachenko E, Isachenko V, Sauer H, Wartenberg M, Tawadros S,
et al. Comparison of necrosis in human ovarian tissue after conventional
slow freezing or vitrification and transplantation in ovariectomized SCID
mice. Reprod Biomed Online. 2004;9:187–93.
12. Rahimi G, Isachenko V, Todorov P, Tawadros S, Mallmann P, Nawaroth F,
et al. Apoptosis in human ovarian tissue after conventional freezing or
vitrification and xenotransplantation. CryoLetters. 2009;30:300–9.
13. Rahimi R, Isachenko V, Kreienberg R, Sauer H, Todorov P, Tawadros S, et al.
Re-vascularisation in human ovarian tissue after conventional freezing or
vitrification and xenotransplantation. Eur J Obstet Gyn R B. 2010;149:63–7.
14. Paynter SJ, Cooper A, Fuller BJ, Shaw RW. Cryopreservation of bovine
ovarian tissue: structural normality of follicles after thawing and culture in
vitro. Cryobiology. 1999;38:301–9.
15. Lucci CM, Kacinskis MA, Lopes LH, Rumpf R, Báo SN. Effect of different
cryoprotectants onthe structural preservation of follicles in frozen zebu
bovine (Bosindicus) ovarian tissue. Theriogenology. 2004;61:1101–14.
Isachenko et al. Reproductive Biology and Endocrinology  (2016) 14:79 Page 9 of 10
16. Isachenko V, Isachenko E, Reinsberg J, Montag M, Weiss J, Braun F, et al.
Simplified technique of human ovarian tissue freezing: quick cooling from
-36° C. CryoLetters. 2008;29:261–8.
17. Isachenko V, Lapidus I, Isachenko E, Krivokharchenko A, Kreienberg R,
Woriedh M, et al. Vitrification and conventional freezing of human ovarian
tissue: morphological, endocrinological and molecular biological evaluation.
Reproduction. 2009;138:319–27.
18. Gook DA, Edgar DH. Ovarian tissue cryopreservation. In: Donnez J, Kim S,
editors. Principles and practice of fertility preservation. New York:
Cambridge University Press; 2011. p. 342–56.
19. Isachenko V, Isachenko E, Mallmann P, Rahimi G. Long-time cooling of
human ovarian tissue before cryopreservation as obvious procedure:
stimulation of follicular development and neo-vascularisation. Clin Lab.
2012;58:1293–300.
20. Mattson M, Chan S. Calcium orchestrates apoptosis. Nat Cell Biol. 2003;5:1041–3.
21. Chiarugi A, Moskowitz M. PARP-1—a perpetrator of apoptotic cell death?
Science. 2002;297:259–63.
22. Ortega-Ferrusola C, González Fernández L, Morrell J, Salazar Sandoval C,
Macías García B, Rodríguez-Martinez H, et al. Lipid peroxidation, assessed
with BODIPY-C11, increases after cryopreservation of stallion spermatozoa, is
stallion-dependent and is related to apoptotic-like changes. Reproduction.
2009;138:55–63.
23. Soleimani R, Heytens E, Oktay K. Enhancement of neoangiogenesis and
follicle survival by sphingosine-1-phosphate in human ovarian tissue
xenotransplants. PLoS One. 2011;6:e19475.
24. Vermes I, Haanen C, Reutelingsperger C. A novel assay for apoptosis:flow
cytometric detection of phosphatidylserine detection of phosphatidylserine
expression on early apoptotic cells usingfluorescence labelled annexin V. J
Immunol Methods. 1995;184:39–51.
25. Galluzzi L, Maiuri M, Vitale I, Zischka H, Castedo M, Zitvogel L, et al. Cell
death modalities: classification and pathophysiological implications. Cell
Death Differ. 2007;4:1237–66.
26. Galluzzi L, Aaronson S, Abrams J, Alnemri ES, Andrews DW, Baehrecke EH,
et al. Guidelines for the use and interpretation of assays for monitoring cell
death in higher eukaryotes. Cell Death Differ. 2009;16:1093–107.
27. Lagasse E, Weissman I. bcl-2 inhibits apoptosis of neutrophils but not their
engulfment by macrophages. J Exp Med. 1994;179:1047–52.
28. Qu X, Zou Z, Sun Q, Luby-Phelps K, Cheng P, Hogan RN, et al. Autophagy
genedependent clearance of apoptotic cells during embryonic
development. Cell. 2007;128:931–46.
29. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH,
et al. Classification of cell death: recommendations of the Nomenclature
Committee on Cell Death. Cell Death Differ. 2009;16:3–11.
30. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA. Apoptosis and
necrosis: two distinct events induced, respectively, by mild and intense
insults with N-methyl-Daspartate or nitric oxide/superoxide in cortical cell
cultures. Proc Natl Acad Sci U S A. 1995;92:7162–6.
31. Chekeni F, Elliott M, Sandilos J, Walk SF, Kinchen JM, Lazarowski ER, et al.
Pannexin 1 channels mediate ‘find-me’ signal release and membrane
permeability during apoptosis. Nature. 2010;467:863–77.
32. Smitz J, Cortvrindt R. The earliest stages of folliculogenesis in vitro.
Reproduction. 2002;123:185–202.
33. Hovatta O. Methods for cryopreservation of human ovarian tissue. Reprod
Biomed Online. 2005;10:729–34.
34. Weissman A, Gotlieb L, Colgan T, Jurisicova A, Greenblatt EM, Casper RF.
Preliminary experience with subcutaneous human ovarian cortex
transplantation in the NOD-SCID mouse. Biol Reprod. 1999;6:1462–7.
35. Dissen GA, Lara HE, Fahrenbach WH. Immature rat ovaries become
revascularized rapidly after autotransplantation and show a gonadotropin-
dependent increase in angiogenic factor gene expression. Endocrinology.
1994;134:1146–54.
36. Delgado-Rosas F, Gaytán M, Morales C, Gómez R, Gaytán F. Superficial
ovarian cortex vascularization is inversely related to the follicle reserve in
normal cycling ovaries and is increased in polycystic ovary syndrome. Hum
Reprod. 2009;24:1142–51.
37. Kim SS, Soules MR, Battaglia DE. Follicular development, ovulation, and
corpus luteum formation in cryopreserved human ovarian tissue after
xenotransplantation. Fertil Steril. 2002;78:77–82.
38. Aubard Y, Piver P, Cogni Y, Fermeaux V, Poulin N, Driancourt MA.
Orthotopic and heterotopic autografts of frozen-thawed ovarian cortex in
sheep. Hum Reprod. 1999;14:2149–54.
39. Baird DT, Webb R, Campbell BK, Harkness LM, Gosden RG. Long-term
ovarian function in sheep after ovariectomy and transplantation of
autografts stored at -196 C. Endocrinology. 1999;140:462–71.
40. Nisolle M, Casanas-Roux F, Qu J, Motta P, Donnez J. Histologic and
ultrastructural evaluation of fresh and frozen-thawed human ovarian
xenografts in nude mice. Fertil Steril. 2000;74:122–9.
41. Donnez J, Martinez-Madrid B, Jadoul P, Van Langendonckt A, Demylle D,
Dolmans MM. Ovarian tissue cryopreservation and transplantation: a review.
Hum Reprod Update. 2006;12:519–35.
42. Dolmans M, Martinez-Madrid B, Gadisseux E, Guiot Y, Yuan WY, Torre A,
et al. Short-term transplantation of isolated human ovarian follicles and
cortical tissue into nude mice. Reproduction. 2007;134:253–62.
43. Isachenko V, Mallmann P, Petrunkina AM, Rahimi G, Nawroth F, Hancke K,
et al. Comparison of in vitro- and chorioallantoic membrane (CAM)-culture
systems for cryopreserved medulla-contained human ovarian tissue. PLoS
One. 2012;73:e32549.
44. Revel A, Laufer N, Ben Meir A, Lebovich M, Mitrani E. Micro-organ
ovarian transplantation enables pregnancy: a case report. Hum Reprod.
2011;26:1097–103.
45. Meirov D. Transplantation of cryopreserved ovarian tissue. In: Chian RC,
Quinn P, editors. Fertility cryopreservation. New York: Cambridge University
Press; 2010. p. 218–32.
46. Soares M, Sahrari K, Chiti MC, Amorim CA, Ambroise J, Donnez J, Dolmans MM.
The best source of isolated stromal cells for the artificial ovary: medulla or
cortex, cryopreserved or fresh? Hum Reprod. 2015;30:1589–98.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Isachenko et al. Reproductive Biology and Endocrinology  (2016) 14:79 Page 10 of 10
